Sandbox Reserved 1652: Difference between revisions
From Proteopedia
Jump to navigationJump to search
Chloe Reynas (talk | contribs) No edit summary |
Chloe Reynas (talk | contribs) No edit summary |
||
| Line 55: | Line 55: | ||
However, the orientation of <scene name='86/868185/L515/1'>L515</scene> and <scene name='86/868185/M547/1'>M547</scene> makes this region of the vanilloid pocket narrow, which considerably limits the nature of the fragments tolerated.<ref name="Understanding TRPV1 activation by ligands: Insights from the binding modes of capsaicin and resiniferatoxin"/> | However, the orientation of <scene name='86/868185/L515/1'>L515</scene> and <scene name='86/868185/M547/1'>M547</scene> makes this region of the vanilloid pocket narrow, which considerably limits the nature of the fragments tolerated.<ref name="Understanding TRPV1 activation by ligands: Insights from the binding modes of capsaicin and resiniferatoxin"/> | ||
The aromatic part of resiniferatoxin is located deeper in the sub-pocket near <scene name='86/868185/Y511/2'>Y511</scene> and is oriented almost parallel to the aromatic side chain of <scene name='86/868185/Y511/2'>Y511</scene>, so it establishes a strong interaction π-π. The aromatic hydroxyl and methoxy groups of the RTX form strong hydrogen bonds with <scene name='86/868185/E570/2'>E570</scene>, <scene name='86/868185/R557/1'>R557</scene> and <scene name='86/868185/S512/1'>S512</scene>. The ester group is linked to <scene name='86/868185/Y511/2'>Y511</scene> and <scene name='86/868185/T550/2'>T550</scene> by hydrogen bonds. | The aromatic part of resiniferatoxin is located deeper in the sub-pocket near <scene name='86/868185/Y511/2'>Y511</scene> and is oriented almost parallel to the aromatic side chain of <scene name='86/868185/Y511/2'>Y511</scene>, so it establishes a strong interaction π-π. The aromatic hydroxyl and methoxy groups of the RTX form strong hydrogen bonds with <scene name='86/868185/E570/2'>E570</scene>, <scene name='86/868185/R557/1'>R557</scene> and <scene name='86/868185/S512/1'>S512</scene>. The ester group is linked to <scene name='86/868185/Y511/2'>Y511</scene> and <scene name='86/868185/T550/2'>T550</scene> by hydrogen bonds. | ||
=== Regulation === | === Regulation === | ||
====Sensitization==== | ====Sensitization==== | ||
| Line 75: | Line 74: | ||
Many laboratories are conducting clinical studies on oral TRPV1 antagonists: GlaxoSmithKline, Amgen, Merk-Neurogen, Abbot, Eli-Lilly-Glenmark, AstraZeneca and Japan Tobacco. The major problem with these pain relievers is the [https://en.wikipedia.org/wiki/Hyperthermia hyperthermia] generated in humans by AMG517 (Amgen lab) and ABT-102 (Abbott lab). These effects caused these studies to be stopped in phase I.<ref name="TRPV1 dans les neuropathies douloureuses - Des modèles animaux aux perspectives thérapeutiques"/> | Many laboratories are conducting clinical studies on oral TRPV1 antagonists: GlaxoSmithKline, Amgen, Merk-Neurogen, Abbot, Eli-Lilly-Glenmark, AstraZeneca and Japan Tobacco. The major problem with these pain relievers is the [https://en.wikipedia.org/wiki/Hyperthermia hyperthermia] generated in humans by AMG517 (Amgen lab) and ABT-102 (Abbott lab). These effects caused these studies to be stopped in phase I.<ref name="TRPV1 dans les neuropathies douloureuses - Des modèles animaux aux perspectives thérapeutiques"/> | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
